Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 2-(acetylamino)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester is a chemical compound that is commonly used in the pharmaceutical and chemical industries. It is a methyl ester derivative of benzoic acid, which is a crystalline solid with a sweet odor.
Used in Pharmaceutical Industry:
Benzoic acid, 2-(acetylamino)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester is used as a precursor in the synthesis of various pharmaceuticals. It is utilized in the development of new drugs and the improvement of existing ones.
Used in Agrochemical Industry:
Benzoic acid, 2-(acetylamino)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester is used as a precursor in the synthesis of various agrochemicals. It helps in the development of new pesticides and herbicides to improve crop yields and protect plants from pests.
Used in Organic Synthesis:
Benzoic acid, 2-(acetylamino)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester is used as a reagent in organic synthesis. It is particularly useful in the preparation of complex molecules, which can be employed in various applications, such as drug development and material science.
Used in Material Science:
Benzoic acid, 2-(acetylamino)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester is a useful building block in the development of new materials and chemical processes. It contributes to the advancement of innovative materials with improved properties and performance.

760989-61-5

Post Buying Request

760989-61-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

760989-61-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 760989-61-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,0,9,8 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 760989-61:
(8*7)+(7*6)+(6*0)+(5*9)+(4*8)+(3*9)+(2*6)+(1*1)=215
215 % 10 = 5
So 760989-61-5 is a valid CAS Registry Number.

760989-61-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-acetamido-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

1.2 Other means of identification

Product number -
Other names 2-acetylamino-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:760989-61-5 SDS

760989-61-5Relevant academic research and scientific papers

BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF

-

Paragraph 0818, (2015/01/06)

The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, Alzheimer's disease), as well as methods of treating these diseases.

BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF

-

, (2013/10/21)

The present invention relates to certain compounds (e.g., imidazopyrazine, imidazopyridine, imidazopyridazine and imidazpyrimidine compounds) that act as inhibitors of the MAP kinase interacting kinases MNK2a, MNK2b, MNK1a, and MNK1b. The present invention further relates to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the preparation of a medicament for the prophylaxis and treatment of diseases (e.g., proliferative diseases (e.g., cancer), inflammatory diseases, Alzheimer's disease), as well as methods of treating these diseases

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 760989-61-5